PathoQuest receives PM’up Relance Industrie Île-de-France grant to expand biologic testing capabilities at Paris site
Pour la version en français de ce communiqué de presse : cliquez iciCompany awarded €500,000 to support scale up and industrialization of its facilities dedicated to quality control testing for biologicsParis, France – November 26, 2020 – PathoQuest, a genomic expert...
Charles River and PathoQuest Strengthen Strategic Partnership
Pour la version en français de ce communiqué de presse : cliquez ici PathoQuest establishes U.S. subsidiary with state-of-the-art biologics genomic testing laboratory in Wayne, PA to expand its next-generation sequencing capabilities.WILMINGTON, MA and PARIS, FRANCE,...
COVID-19: PathoQuest services continuity update
More than ever, we remain by your side. The COVID-19 pandemic has continued to rapidly evolve; many countries are facing the challenges of very high global risk levels. During health emergencies like this pandemic, one of PathoQuest roles is to continue to provide...
PathoQuest obtains Pharmaceutical Establishment status from French ANSM for its biological drug testing activities
Pour la version en français de ce communiqué de presse : cliquez ici Paris, France - September 29, 2020 – PathoQuest, a leader in quality control solutions based on the company’s expertise and use of cutting-edge genomic sequencing technology, announced that it has...
PathoQuest’s Paris Based Facility Obtains GLP Conformity Certificate for its Biologics Genomic Testing Services Based on Next-Generation Sequencing Technology.
Pour la version en français de ce communiqué de presse : cliquez ici PARIS, FRANCE, January 23, 2020 – PathoQuest, a company with expertise in genomic analysis, announced today that it has received GLP certificate of conformity following a successful inspection by the...
PathoQuest Secures 8 Million Euros in New Financing
Paris, FRANCE -- (BUSINESS WIRE) -- September 5, 2019 -- PathoQuest, a genomic expert company dedicated to the microbiology testing market and a leader in clinical diagnostics and biologics testing applications, today announces the closing of an 8M euros financing...
PathoQuest Names Dr. Christiane Honisch to Board of Directors
PARIS, FRANCE – September 25, 2018 -- PathoQuest, a genomic expert dedicated to the microbiology testing market, leader in clinical diagnostics and biologics testing applications, today announced the appointment of Christiane Honisch, Ph.D. as an...
PathoQuest Announces New Appointments to Executive Leadership Team
Company adds experienced executives to support the continued growth of Biologics Genomic Service and Clinical Diagnostics businesses which utilize PathoQuest’s proprietary Next-Generation Sequencing (NGS) based testing solution. PARIS, FRANCE – July 10,...
PathoQuest announces enrollment of first patient in IDENTIFY, a prospective clinical study assessing the medico-economic benefit of iDTECT™ Blood for the diagnosis of bloodstream infection in immunocompromised patients
Pour la version en français de ce communiqué de presse : cliquez ici PARIS, FRANCE, May 22, 2018 – PathoQuest, a genomic expert for biologics testing and a leader in improving pathogen identification in clinical biological samples, today announced the...
Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership
Partnership Charles River will provide clients access to PathoQuest’s NGS-based testing solutions WILMINGTON, MA and PARIS, FRANCE, April 9, 2018 – Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest today announced an expansion of...